Skip to main content
. 2020 Aug 16;30(8):451–460. doi: 10.1016/j.tcm.2020.08.002

Table 2.

Mechanisms of Arrhythmogenicity in Patients with COVID-19 Infection.

Acute myocardial injury / Myocarditis
Hypoxia
Systemic inflammation
Autonomic imbalance (SNS overactivity / virus-induced vagal nerve injury)
Electrolyte abnormalities
QT prolonging drugs (anti-COVID pharmacotherapies / AADs / other agents)
Drug-drug interactions
Cardiovascular comorbidities (hypertension, coronary artery disease, cardiomyopathy)

AADs = antiarrhythmic drugs; SNS = sympathetic nervous system.